January 1, 2019
Last week, the Knesset approved the amendment to the Dangerous Drugs Ordinance, which will allow the export of medical cannabis in the future. Adv. Yoav Etzyon, partner and co-head of the firm’s High Tech and Venture Capital Department, and Nir Stanger wrote a newsletter summarizing the new regulatory changes.
To the newsletter, click here